AHA responds to GOP inquiry on drug shortages, shares impact on hospitals and patient care 

AHA is weighing in on drug shortages that impact patient care in response to a request by Republican leaders in the House and Senate. Rep. Cathy McMorris Rodgers, R-Wash., chair of the House Committee on Energy and Commerce, and Sen. Mike Crapo, R-Idaho, ranking member of the Senate Finance Committee, sought the information to better understand the issue. In its response, AHA described the wide range of shortages that impact patients suffering from a vast array of illnesses. AHA urged a number of actions, including strengthening the supply chain for prescription drugs, diversifying manufacturing sites and increasing end-user inventories, along with steps the Food and Drug Administration can take to further stabilize the nation’s supply of essential drugs.